Search results
Showing 151 to 200 of 2052 results for work
Tell us what matters to you, your organisation or your community.
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios for principle social workers Principle social...
Help with registering for your NHS OpenAthens account.
This quality standard covers the mental wellbeing of older people (aged 65 and over) receiving care in care homes (including residential and nursing accommodation, day care and respite care). It focuses on support for people to improve their mental wellbeing so that they can stay as well and independent as possible. It describes high-quality care in priority areas for improvement.
View quality statements for QS50Show all sections
Sections for QS50
- Quality statements
- Quality statement 1: Participation in meaningful activity
- Quality statement 2: Personal identity
- Quality statement 3: Recognition of mental health conditions
- Quality statement 4: Recognition of sensory impairment
- Quality statement 5: Recognition of physical problems
- Quality statement 6: Access to healthcare services
- Update information
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios for principle social workers Principle social...
NICE Listens is our programme of deliberative public engagement. It's used to give us an understanding of public opinion on moral, ethical and social value issues.
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios for principle social workers...
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios for principle social workers Principle social...
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios Services for older people...
Science policy projects with NICE.
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios...
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios Families and relationships settings...
a stakeholder People and communities - putting you at the heart of our work Help develop quality standards Help us improve Help...
a stakeholder People and communities - putting you at the heart of our work Help develop quality standards Help us improve Help...
This guideline covers systems and processes for using and managing controlled drugs safely in all NHS settings except care homes. It aims to improve working practices to comply with legislation and have robust governance arrangements. It also aims to reduce the safety risks associated with controlled drugs.
This guideline covers diagnosing and managing endometriosis, including where fertility is a priority. It aims to raise awareness of endometriosis symptoms, and to provide clear advice on referral, diagnosis and the range of treatments available.
We assess the efficacy and safety of interventional procedures used for treatment or diagnosis to determine whether they work well enough and are safe enough for use in the NHS.
We want you to be involved in our work - whether you’re commenting on our draft recommendations, taking part in guidance development or attending a committee meeting, your voice is important to us.
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios Learning disability settings...
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios Families and relationships settings...
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios Learning disability settings...
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios Mental health services...
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios Mental health services...
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios Learning disability settings...
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios...
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios for principle social workers...
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios Mental health services...
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios Families and relationships settings...
Home What NICE does Our research work HTA Lab...
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios...
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios for principle social workers...
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios Services for older people...
NICE's partners
Getting involved as a voluntary and community sector organisation
Getting involved with NICE as a voluntary and community sector organisation
Getting involved as a voluntary and community sector organisation
Getting involved with NICE as a voluntary and community sector organisation
experiences of people who use services:- What approaches have been shown to work in supporting the co-production of research for the...
Guselkumab for previously treated moderately to severely active Crohn's disease (TA1095)
Evidence-based recommendations on guselkumab (Tremfya) for previously treated moderately to severely active Crohn's disease.
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios for principle social workers Principle social...
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios Services for older people...
Home Implementing NICE guidance Social care Using NICE guidance in social work: scenarios for principle social workers Principle social...
Home What NICE does Our research work...
Harmful sexual behaviour among children and young people (NG55)
This guideline covers children and young people who display harmful sexual behaviour, including those on remand or serving community or custodial sentences. It aims to ensure these problems don’t escalate and possibly lead to them being charged with a sexual offence. It also aims to ensure no-one is unnecessarily referred to specialist services.
Our projects and partnerships help us anticipate and adapt to policy developments, including changes in health and social care delivery.
Our role in the Innovative Licensing and Access Pathway (ILAP)
The Innovative Licensing and Access Pathway (ILAP) is a unique initiative which works with medicine developers early on to help get new medicines to patients faster.
Coeliac disease: recognition, assessment and management (NG20)
This guideline covers the recognition, assessment and management of coeliac disease in children, young people and adults.
This guideline covers rehabilitation strategies for adults who have experienced a critical illness and stayed in critical care. It aims to improve physical, psychological and cognitive outcomes in people who have been discharged from critical care.
Transient loss of consciousness ('blackouts') in over 16s (CG109)
This guideline covers assessment, diagnosis and referral for people over 16 who have had a transient loss of consciousness (TLoC; also called a blackout). It aims to improve care for people with TLoC by specifying the most effective assessments and recommending when to refer to a specialist.
This quality standard covers diagnosing and managing epilepsies in children, young people and adults. It describes high-quality care in priority areas for improvement.
View quality statements for QS211Show all sections
Sections for QS211
- Quality statements
- Quality statement 1: Referral and assessment after first seizure
- Quality statement 2: Referral to tertiary specialist services
- Quality statement 3: Epilepsy specialist nurse
- Quality statement 4: Epilepsy care plan
- Quality statement 5: Mental health and wellbeing
- Quality statement 6: Neurodevelopment and learning disabilities
- Update information
We provide an advisory service for international health organisations, ministries and government agencies whose task is to improve evidence-based decision making in health and social care.
Tislelizumab with chemotherapy for untreated advanced oesophageal squamous cell cancer [ID5113]
In development Reference number: GID-TA11025 Expected publication date: TBC